These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31100828)

  • 101. Effects of Omega-3 Fatty Acids on Immune Cells.
    Gutiérrez S; Svahn SL; Johansson ME
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614433
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
    Wang A; Zhong H
    Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
    [TBL] [Abstract][Full Text] [Related]  

  • 103. [Angiogenesis in patients with hematologic malignancies].
    Mesters RM; Padró T; Steins M; Bieker R; Retzlaff S; Kessler T; Kienast J; Berdel WE
    Onkologie; 2001 Sep; 24 Suppl 5():75-80. PubMed ID: 11600818
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Polyunsaturated fatty acids in inflammatory bowel diseases: a reappraisal of effects and therapeutic approaches.
    Marion-Letellier R; Savoye G; Beck PL; Panaccione R; Ghosh S
    Inflamm Bowel Dis; 2013 Mar; 19(3):650-61. PubMed ID: 23328774
    [TBL] [Abstract][Full Text] [Related]  

  • 105. An ARC-Regulated IL1β/Cox-2/PGE2/β-Catenin/ARC Circuit Controls Leukemia-Microenvironment Interactions and Confers Drug Resistance in AML.
    Carter BZ; Mak PY; Wang X; Tao W; Ruvolo V; Mak D; Mu H; Burks JK; Andreeff M
    Cancer Res; 2019 Mar; 79(6):1165-1177. PubMed ID: 30674535
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Eicosanoid and Specialized Proresolving Mediator Regulation of Lymphoid Cells.
    Wei J; Gronert K
    Trends Biochem Sci; 2019 Mar; 44(3):214-225. PubMed ID: 30477730
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Stable Isotope Labeling Highlights Enhanced Fatty Acid and Lipid Metabolism in Human Acute Myeloid Leukemia.
    Stuani L; Riols F; Millard P; Sabatier M; Batut A; Saland E; Viars F; Tonini L; Zaghdoudi S; Linares LK; Portais JC; Sarry JE; Bertrand-Michel J
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30366412
    [No Abstract]   [Full Text] [Related]  

  • 108. Inhibition of 15-PGDH causes Kras-driven tumor expansion through prostaglandin E2-ALDH1 signaling in the pancreas.
    Arima K; Ohmuraya M; Miyake K; Koiwa M; Uchihara T; Izumi D; Gao F; Yonemura A; Bu L; Okabe H; Imai K; Hashimoto D; Baba Y; Chikamoto A; Yamashita YI; Furukawa T; Araki K; Baba H; Ishimoto T
    Oncogene; 2019 Feb; 38(8):1211-1224. PubMed ID: 30250298
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Low Plasma Omega-3 Fatty Acid Levels May Predict Inferior Prognosis in Untreated Diffuse Large B-Cell Lymphoma: A New Modifiable Dietary Biomarker?
    Thanarajasingam G; Maurer MJ; Habermann TM; Nowakowski GS; Bennani NN; Thompson CA; Cerhan JR; Witzig TE
    Nutr Cancer; 2018 Oct; 70(7):1088-1090. PubMed ID: 30235018
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Specific oxylipins enhance vertebrate hematopoiesis via the receptor GPR132.
    Lahvic JL; Ammerman M; Li P; Blair MC; Stillman ER; Fast EM; Robertson AL; Christodoulou C; Perlin JR; Yang S; Chiang N; Norris PC; Daily ML; Redfield SE; Chan IT; Chatrizeh M; Chase ME; Weis O; Zhou Y; Serhan CN; Zon LI
    Proc Natl Acad Sci U S A; 2018 Sep; 115(37):9252-9257. PubMed ID: 30139917
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Targeting lipid mediators in cancer biology.
    Sulciner ML; Gartung A; Gilligan MM; Serhan CN; Panigrahy D
    Cancer Metastasis Rev; 2018 Sep; 37(2-3):557-572. PubMed ID: 30136088
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Combination therapy of omega-3 fatty acids and acipimox for children with hypertriglyceridemia and acute lymphoblastic leukemia.
    Salvador C; Entenmann A; Salvador R; Niederwanger A; Crazzolara R; Kropshofer G
    J Clin Lipidol; 2018; 12(5):1260-1266. PubMed ID: 30055974
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Effects of the polyunsaturated fatty acids, EPA and DHA, on hematological malignancies: a systematic review.
    Moloudizargari M; Mortaz E; Asghari MH; Adcock IM; Redegeld FA; Garssen J
    Oncotarget; 2018 Feb; 9(14):11858-11875. PubMed ID: 29545942
    [TBL] [Abstract][Full Text] [Related]  

  • 114. A second-generation 15-PGDH inhibitor promotes bone marrow transplant recovery independently of age, transplant dose and granulocyte colony-stimulating factor support.
    Desai A; Zhang Y; Park Y; Dawson DM; Larusch GA; Kasturi L; Wald D; Ready JM; Gerson SL; Markowitz SD
    Haematologica; 2018 Jun; 103(6):1054-1064. PubMed ID: 29472361
    [TBL] [Abstract][Full Text] [Related]  

  • 115. The influence of peroxisome proliferator-activated receptor γ (PPARγ) ligands on cancer cell tumorigenicity.
    Yousefnia S; Momenzadeh S; Seyed Forootan F; Ghaedi K; Nasr Esfahani MH
    Gene; 2018 Apr; 649():14-22. PubMed ID: 29369787
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Anti-leukemic effects of PPARγ ligands.
    Ryu S; Kim DS; Lee MW; Lee JW; Sung KW; Koo HH; Yoo KH
    Cancer Lett; 2018 Apr; 418():10-19. PubMed ID: 29331412
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Downregulation of 15-hydroxyprostaglandin dehydrogenase by interleukin-1β from activated macrophages leads to poor prognosis in pancreatic cancer.
    Arima K; Komohara Y; Bu L; Tsukamoto M; Itoyama R; Miyake K; Uchihara T; Ogata Y; Nakagawa S; Okabe H; Imai K; Hashimoto D; Chikamoto A; Yamashita YI; Baba H; Ishimoto T
    Cancer Sci; 2018 Feb; 109(2):462-470. PubMed ID: 29224225
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Resolvins suppress tumor growth and enhance cancer therapy.
    Sulciner ML; Serhan CN; Gilligan MM; Mudge DK; Chang J; Gartung A; Lehner KA; Bielenberg DR; Schmidt B; Dalli J; Greene ER; Gus-Brautbar Y; Piwowarski J; Mammoto T; Zurakowski D; Perretti M; Sukhatme VP; Kaipainen A; Kieran MW; Huang S; Panigrahy D
    J Exp Med; 2018 Jan; 215(1):115-140. PubMed ID: 29191914
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Immunotherapy for acute myeloid leukemia (AML): a potent alternative therapy.
    Acheampong DO; Adokoh CK; Asante DB; Asiamah EA; Barnie PA; Bonsu DOM; Kyei F
    Biomed Pharmacother; 2018 Jan; 97():225-232. PubMed ID: 29091870
    [TBL] [Abstract][Full Text] [Related]  

  • 120. The progress and current status of immunotherapy in acute myeloid leukemia.
    Yang D; Zhang X; Zhang X; Xu Y
    Ann Hematol; 2017 Dec; 96(12):1965-1982. PubMed ID: 29080982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.